SynthesisPloS one2018

Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.

Ruimei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.